SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-130005
Filing Date
2020-11-27
Accepted
2020-11-27 17:16:58
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2036932d1_s3.htm S-3 198052
2 EXHIBIT 5.1 tm2036932d1_ex5-1.htm EX-5.1 26390
3 EXHIBIT 23.1 tm2036932d1_ex23-1.htm EX-23.1 4289
4 GRAPHIC tm2036932d1_s3img001.jpg GRAPHIC 14904
5 GRAPHIC tm2036932d1_s3img002.jpg GRAPHIC 10922
6 GRAPHIC ex5-1_img.jpg GRAPHIC 3142
  Complete submission text file 0001104659-20-130005.txt   270074
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251005 | Film No.: 201355900
SIC: 2834 Pharmaceutical Preparations